Ad35-GRIN

BIOLOGICAL2 trials

Sponsors

International AIDS Vaccine Initiative, University of Oxford

Conditions

AIDSHIVHIV Infections

Phase 1

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

CompletedNCT00851383

International AIDS Vaccine InitiativeHIV, HIV Infections

Start: 2009-03-31End: 2011-08-31Updated: 2012-04-25

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

CompletedNCT02099994

University of OxfordAIDS

Start: 2014-03-31End: 2015-08-31Updated: 2016-05-30

Related Papers

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

PLoS ONE2015-08-0743 citations

A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.

2012-08-0369 citations